⌘+K

Sweden

Technology Hardware & Equipment

Qualisys

Equity Story

Near term

6-12 MONTHS

After modest sales growth in 2025, we expect 2026 to be softer, affected by FX headwinds, the prolonged US-Iran conflict and tariff-related budget delays in the US. We view this as transitory rather than structural, with demand fundamentals supported by a high share of sales to publicly funded universities and research institutions. A return of larger projects, absent in 2025 after three in 2024, could act as a near-term catalyst and is something we will be watching closely in H2 2026. The valuation remains below both its historical average and peer multiples, and as FX normalises and customer activity picks up, we see scope for a return to stronger growth and substantial margin expansion through operating leverage.

Long term

6+ YEARS

We see strong structural growth potential, supported by increasing adoption of motion capture technology. Beyond the near-term noise, we think the more interesting story is developing underneath with the upcoming Prisma Pose launch that will give Qualisys a fully integrated markerless offering, as well as OnTraq that is building an early subscription revenue base. According to MarketsandMarkets, the motion capture TAM is set to see a 15% CAGR from 2024 to 2029, driven by an expanding addressable market to new verticals in healthcare, media and sports, among others. This growth is expected to come from all components in 3D motion capture, including hardware, software and accessories. Qualisys targets sales growth of at least 15% per year over a business cycle, and an EBIT margin of at least 20%.

Key risks

  • Project-related risk.

  • Political and client funding risk.

  • Long procurement cycles and external project delays can cause short-term fluctuations in revenue, profitability, and cash flows. Qualisys’ business is best assessed over longer periods, e.g., annual performance.

  • Volatility in profitability and cash flows based on currency fluctuations.

Fair value range

Price

Fair range high value

Fair range low value

The high end of our fair value range is based on a 2027e EV/EBIT of 13x, and the low end 10x.

Valuation and methodology

Our fair value range is based on a peer group multiples valuation approach.

Key metrics

About DNB Carnegie Access

DNB Carnegie Access aim is to connect listed companies with the capital markets. Through top ranked public equity research and broad distribution via written reports, seminars, video, and podcasts, we increase visibility and investor understanding for small- and medium-sized companies, both among institutional and private investors.

Along with corporate finance, market making and certified advisory we provide a complete product offering to our clients.

Private Banking

Tailored wealth management. Your financial future, personalized.

Montrose

A digital investment platform designed for passionate investors.

DNB Carnegie

Leading Nordic investment bank and wealth management.

© Copyright DNB Carnegie Investment Bank AB